BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
M.D. Anderson Cancer Center
University of California, Irvine
Astellas Pharma Inc
Pfizer
Amgen
Merck Sharp & Dohme LLC
NRG Oncology
Eli Lilly and Company
Shanghai Zhongshan Hospital
Boehringer Ingelheim
Xijing Hospital
AstraZeneca
BioNTech SE
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Zai Lab (Hong Kong), Ltd.
RayzeBio, Inc.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
University of Pittsburgh
University of Chicago
Peking University Cancer Hospital & Institute
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
Innovent Biologics (Suzhou) Co. Ltd.
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Taiho Pharmaceutical Co., Ltd.
Hansoh BioMedical R&D Company
Hansoh BioMedical R&D Company
Shanghai Jiao Tong University School of Medicine